Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB (change energy unit to kcal/mol)
Found 127 hits in this display
BDBM50241354(2-(3,4-Dihydroxy-phenyl)-5,7-dihydroxy-3-(3,4,5-tr...)
BDBM50241354(2-(3,4-Dihydroxy-phenyl)-5,7-dihydroxy-3-(3,4,5-tr...)
BDBM50241354(2-(3,4-Dihydroxy-phenyl)-5,7-dihydroxy-3-(3,4,5-tr...)
BDBM50241354(2-(3,4-Dihydroxy-phenyl)-5,7-dihydroxy-3-(3,4,5-tr...)
BDBM86036(CAS_5318390 | CAS_97331 | Hyperoside | Miquelianin...)
BDBM50241354(2-(3,4-Dihydroxy-phenyl)-5,7-dihydroxy-3-(3,4,5-tr...)
BDBM86036(CAS_5318390 | CAS_97331 | Hyperoside | Miquelianin...)
BDBM50318294(CHEMBL1098724 | miquelianin)
BDBM50241354(2-(3,4-Dihydroxy-phenyl)-5,7-dihydroxy-3-(3,4,5-tr...)
BDBM50241354(2-(3,4-Dihydroxy-phenyl)-5,7-dihydroxy-3-(3,4,5-tr...)
BDBM86036(CAS_5318390 | CAS_97331 | Hyperoside | Miquelianin...)
BDBM86036(CAS_5318390 | CAS_97331 | Hyperoside | Miquelianin...)
BDBM86036(CAS_5318390 | CAS_97331 | Hyperoside | Miquelianin...)
BDBM86036(CAS_5318390 | CAS_97331 | Hyperoside | Miquelianin...)
BDBM86036(CAS_5318390 | CAS_97331 | Hyperoside | Miquelianin...)
BDBM86036(CAS_5318390 | CAS_97331 | Hyperoside | Miquelianin...)
BDBM86036(CAS_5318390 | CAS_97331 | Hyperoside | Miquelianin...)
BDBM86036(CAS_5318390 | CAS_97331 | Hyperoside | Miquelianin...)
BDBM86036(CAS_5318390 | CAS_97331 | Hyperoside | Miquelianin...)
BDBM86036(CAS_5318390 | CAS_97331 | Hyperoside | Miquelianin...)
BDBM86036(CAS_5318390 | CAS_97331 | Hyperoside | Miquelianin...)
BDBM86036(CAS_5318390 | CAS_97331 | Hyperoside | Miquelianin...)
BDBM50241354(2-(3,4-Dihydroxy-phenyl)-5,7-dihydroxy-3-(3,4,5-tr...)
BDBM50241354(2-(3,4-Dihydroxy-phenyl)-5,7-dihydroxy-3-(3,4,5-tr...)
BDBM86036(CAS_5318390 | CAS_97331 | Hyperoside | Miquelianin...)
BDBM86036(CAS_5318390 | CAS_97331 | Hyperoside | Miquelianin...)
BDBM86036(CAS_5318390 | CAS_97331 | Hyperoside | Miquelianin...)
BDBM86036(CAS_5318390 | CAS_97331 | Hyperoside | Miquelianin...)
BDBM86036(CAS_5318390 | CAS_97331 | Hyperoside | Miquelianin...)
BDBM86036(CAS_5318390 | CAS_97331 | Hyperoside | Miquelianin...)
BDBM86036(CAS_5318390 | CAS_97331 | Hyperoside | Miquelianin...)
BDBM86036(CAS_5318390 | CAS_97331 | Hyperoside | Miquelianin...)
BDBM86036(CAS_5318390 | CAS_97331 | Hyperoside | Miquelianin...)
BDBM86036(CAS_5318390 | CAS_97331 | Hyperoside | Miquelianin...)
BDBM86036(CAS_5318390 | CAS_97331 | Hyperoside | Miquelianin...)
BDBM86036(CAS_5318390 | CAS_97331 | Hyperoside | Miquelianin...)
BDBM86036(CAS_5318390 | CAS_97331 | Hyperoside | Miquelianin...)
BDBM86036(CAS_5318390 | CAS_97331 | Hyperoside | Miquelianin...)
BDBM86036(CAS_5318390 | CAS_97331 | Hyperoside | Miquelianin...)
BDBM86036(CAS_5318390 | CAS_97331 | Hyperoside | Miquelianin...)
BDBM86036(CAS_5318390 | CAS_97331 | Hyperoside | Miquelianin...)
BDBM86036(CAS_5318390 | CAS_97331 | Hyperoside | Miquelianin...)
BDBM86036(CAS_5318390 | CAS_97331 | Hyperoside | Miquelianin...)
BDBM86036(CAS_5318390 | CAS_97331 | Hyperoside | Miquelianin...)
BDBM86036(CAS_5318390 | CAS_97331 | Hyperoside | Miquelianin...)
BDBM86036(CAS_5318390 | CAS_97331 | Hyperoside | Miquelianin...)
BDBM86036(CAS_5318390 | CAS_97331 | Hyperoside | Miquelianin...)
BDBM86036(CAS_5318390 | CAS_97331 | Hyperoside | Miquelianin...)
BDBM86036(CAS_5318390 | CAS_97331 | Hyperoside | Miquelianin...)
BDBM86036(CAS_5318390 | CAS_97331 | Hyperoside | Miquelianin...)
BDBM86036(CAS_5318390 | CAS_97331 | Hyperoside | Miquelianin...)
BDBM86036(CAS_5318390 | CAS_97331 | Hyperoside | Miquelianin...)
BDBM86036(CAS_5318390 | CAS_97331 | Hyperoside | Miquelianin...)
BDBM86036(CAS_5318390 | CAS_97331 | Hyperoside | Miquelianin...)
BDBM86036(CAS_5318390 | CAS_97331 | Hyperoside | Miquelianin...)
BDBM86036(CAS_5318390 | CAS_97331 | Hyperoside | Miquelianin...)
BDBM86036(CAS_5318390 | CAS_97331 | Hyperoside | Miquelianin...)
BDBM86036(CAS_5318390 | CAS_97331 | Hyperoside | Miquelianin...)
BDBM86036(CAS_5318390 | CAS_97331 | Hyperoside | Miquelianin...)
BDBM86036(CAS_5318390 | CAS_97331 | Hyperoside | Miquelianin...)
BDBM86036(CAS_5318390 | CAS_97331 | Hyperoside | Miquelianin...)
BDBM86036(CAS_5318390 | CAS_97331 | Hyperoside | Miquelianin...)
BDBM86036(CAS_5318390 | CAS_97331 | Hyperoside | Miquelianin...)
BDBM86036(CAS_5318390 | CAS_97331 | Hyperoside | Miquelianin...)
BDBM86036(CAS_5318390 | CAS_97331 | Hyperoside | Miquelianin...)
BDBM86036(CAS_5318390 | CAS_97331 | Hyperoside | Miquelianin...)
BDBM86036(CAS_5318390 | CAS_97331 | Hyperoside | Miquelianin...)
BDBM86036(CAS_5318390 | CAS_97331 | Hyperoside | Miquelianin...)
BDBM86036(CAS_5318390 | CAS_97331 | Hyperoside | Miquelianin...)
BDBM86036(CAS_5318390 | CAS_97331 | Hyperoside | Miquelianin...)
BDBM86036(CAS_5318390 | CAS_97331 | Hyperoside | Miquelianin...)
BDBM86036(CAS_5318390 | CAS_97331 | Hyperoside | Miquelianin...)
BDBM86036(CAS_5318390 | CAS_97331 | Hyperoside | Miquelianin...)
BDBM86036(CAS_5318390 | CAS_97331 | Hyperoside | Miquelianin...)
BDBM86036(CAS_5318390 | CAS_97331 | Hyperoside | Miquelianin...)
BDBM86036(CAS_5318390 | CAS_97331 | Hyperoside | Miquelianin...)
BDBM86036(CAS_5318390 | CAS_97331 | Hyperoside | Miquelianin...)
BDBM86036(CAS_5318390 | CAS_97331 | Hyperoside | Miquelianin...)
BDBM86036(CAS_5318390 | CAS_97331 | Hyperoside | Miquelianin...)
BDBM86036(CAS_5318390 | CAS_97331 | Hyperoside | Miquelianin...)
BDBM86036(CAS_5318390 | CAS_97331 | Hyperoside | Miquelianin...)
BDBM86036(CAS_5318390 | CAS_97331 | Hyperoside | Miquelianin...)
BDBM86036(CAS_5318390 | CAS_97331 | Hyperoside | Miquelianin...)
BDBM86036(CAS_5318390 | CAS_97331 | Hyperoside | Miquelianin...)
BDBM86036(CAS_5318390 | CAS_97331 | Hyperoside | Miquelianin...)
BDBM86036(CAS_5318390 | CAS_97331 | Hyperoside | Miquelianin...)
BDBM50241367(2-(3,4-Dihydroxy-phenyl)-5,7-dihydroxy-3-((2S,4R,5...)
BDBM50318294(CHEMBL1098724 | miquelianin)
BDBM50241354(2-(3,4-Dihydroxy-phenyl)-5,7-dihydroxy-3-(3,4,5-tr...)
BDBM50241367(2-(3,4-Dihydroxy-phenyl)-5,7-dihydroxy-3-((2S,4R,5...)
BDBM50241367(2-(3,4-Dihydroxy-phenyl)-5,7-dihydroxy-3-((2S,4R,5...)
BDBM50241367(2-(3,4-Dihydroxy-phenyl)-5,7-dihydroxy-3-((2S,4R,5...)
BDBM50241367(2-(3,4-Dihydroxy-phenyl)-5,7-dihydroxy-3-((2S,4R,5...)
BDBM50241354(2-(3,4-Dihydroxy-phenyl)-5,7-dihydroxy-3-(3,4,5-tr...)
BDBM50241367(2-(3,4-Dihydroxy-phenyl)-5,7-dihydroxy-3-((2S,4R,5...)
BDBM50241354(2-(3,4-Dihydroxy-phenyl)-5,7-dihydroxy-3-(3,4,5-tr...)
Arginase(Leishmania amazonensis)Universidade Federal De S£O Carlos
Curated by ChEMBL
BDBM50241354(2-(3,4-Dihydroxy-phenyl)-5,7-dihydroxy-3-(3,4,5-tr...)
BDBM50241367(2-(3,4-Dihydroxy-phenyl)-5,7-dihydroxy-3-((2S,4R,5...)
BDBM50241354(2-(3,4-Dihydroxy-phenyl)-5,7-dihydroxy-3-(3,4,5-tr...)
BDBM50241354(2-(3,4-Dihydroxy-phenyl)-5,7-dihydroxy-3-(3,4,5-tr...)
IC50: 4.50E+3nMAssay Description:Inhibition of human recombinant aldose reductase using D-glyceraldehyde as substrate preincubated for 10 mins before substrate addition measured for ...More data for this Ligand-Target Pair
BDBM50241354(2-(3,4-Dihydroxy-phenyl)-5,7-dihydroxy-3-(3,4,5-tr...)
BDBM50241354(2-(3,4-Dihydroxy-phenyl)-5,7-dihydroxy-3-(3,4,5-tr...)
BDBM50241367(2-(3,4-Dihydroxy-phenyl)-5,7-dihydroxy-3-((2S,4R,5...)
BDBM50241354(2-(3,4-Dihydroxy-phenyl)-5,7-dihydroxy-3-(3,4,5-tr...)
BDBM50241354(2-(3,4-Dihydroxy-phenyl)-5,7-dihydroxy-3-(3,4,5-tr...)
BDBM50241354(2-(3,4-Dihydroxy-phenyl)-5,7-dihydroxy-3-(3,4,5-tr...)
BDBM50241354(2-(3,4-Dihydroxy-phenyl)-5,7-dihydroxy-3-(3,4,5-tr...)
BDBM50241354(2-(3,4-Dihydroxy-phenyl)-5,7-dihydroxy-3-(3,4,5-tr...)
BDBM50241354(2-(3,4-Dihydroxy-phenyl)-5,7-dihydroxy-3-(3,4,5-tr...)
BDBM50241354(2-(3,4-Dihydroxy-phenyl)-5,7-dihydroxy-3-(3,4,5-tr...)
BDBM50241354(2-(3,4-Dihydroxy-phenyl)-5,7-dihydroxy-3-(3,4,5-tr...)
BDBM50241367(2-(3,4-Dihydroxy-phenyl)-5,7-dihydroxy-3-((2S,4R,5...)
BDBM50241354(2-(3,4-Dihydroxy-phenyl)-5,7-dihydroxy-3-(3,4,5-tr...)
BDBM50241354(2-(3,4-Dihydroxy-phenyl)-5,7-dihydroxy-3-(3,4,5-tr...)
BDBM50241354(2-(3,4-Dihydroxy-phenyl)-5,7-dihydroxy-3-(3,4,5-tr...)
BDBM50241354(2-(3,4-Dihydroxy-phenyl)-5,7-dihydroxy-3-(3,4,5-tr...)
IC50: 5.13E+4nMT: 2°CAssay Description:The p38alpha reaction was carried out by using kinase (12ng per well), ATP (100uM) and incubated for 60 min at 37 C. For the JNK3 assay, kinase (10n...More data for this Ligand-Target Pair
Neuraminidase(Influenza A virus (strain A/USSR/90/1977 H1N1))Freie Universitaet Berlin
Curated by ChEMBL
BDBM50241367(2-(3,4-Dihydroxy-phenyl)-5,7-dihydroxy-3-((2S,4R,5...)
BDBM50241354(2-(3,4-Dihydroxy-phenyl)-5,7-dihydroxy-3-(3,4,5-tr...)
Neuraminidase(Influenza A virus (strain A/USSR/90/1977 H1N1))Freie Universitaet Berlin
Curated by ChEMBL
BDBM50241367(2-(3,4-Dihydroxy-phenyl)-5,7-dihydroxy-3-((2S,4R,5...)
BDBM50241354(2-(3,4-Dihydroxy-phenyl)-5,7-dihydroxy-3-(3,4,5-tr...)
BDBM50241367(2-(3,4-Dihydroxy-phenyl)-5,7-dihydroxy-3-((2S,4R,5...)
IC50: 1.26E+5nMAssay Description:Inhibition of human OATP2B1 expressed in Flp-In-CHO cells assessed as inhibition of OATP2B1 mediated DBF uptake using DBF as fluorescent substrate in...More data for this Ligand-Target Pair
Integrase(Human immunodeficiency virus 1)Korea Institute Of Science & Technology
Curated by ChEMBL
BDBM50241367(2-(3,4-Dihydroxy-phenyl)-5,7-dihydroxy-3-((2S,4R,5...)
Neuraminidase(Influenza A virus (strain A/USSR/90/1977 H1N1))Freie Universitaet Berlin
Curated by ChEMBL
BDBM50241354(2-(3,4-Dihydroxy-phenyl)-5,7-dihydroxy-3-(3,4,5-tr...)
IC50: 3.70E+5nMAssay Description:Inhibition of influenza A virus (A/California/07/2009(H1N1)) pdm09 neuraminidase using MUNANA substrate pre-incubated for 30 mins before substrate ad...More data for this Ligand-Target Pair
Neuraminidase(Influenza A virus (strain A/USSR/90/1977 H1N1))Freie Universitaet Berlin
Curated by ChEMBL
BDBM50241354(2-(3,4-Dihydroxy-phenyl)-5,7-dihydroxy-3-(3,4,5-tr...)
IC50: 4.77E+5nMAssay Description:Inhibition of influenza A virus (A/Perth/16/2009(H3N2)) neuraminidase using MUNANA substrate pre-incubated for 30 mins before substrate addition by f...More data for this Ligand-Target Pair
BDBM50241354(2-(3,4-Dihydroxy-phenyl)-5,7-dihydroxy-3-(3,4,5-tr...)
BDBM50241354(2-(3,4-Dihydroxy-phenyl)-5,7-dihydroxy-3-(3,4,5-tr...)
Displayed 1 to 50 (of 127 total ) | Next | Last >>